Suggestions
Tao Liu
Group Leader, Histone Modification Group, Children's Cancer Institute Australia
Dr. Tao Liu is a prominent researcher and group leader at the Children's Cancer Institute Australia, specializing in neuroblastoma research.12 He leads the Gene Dysregulation Group and holds the position of conjoint Associate Professor in the UNSW Faculty of Medicine.2
Background and Education
Dr. Liu was originally trained as a medical practitioner specializing in neurology.23 He obtained his BMed from Suzhou Medical College, Suzhou University, China (1982-1987), MMed from Shanghai Medical University, China (1987-1990), and PhD from the University of New South Wales, Sydney, Australia (1998-2000).3
Career Progression
Dr. Liu joined the Children's Cancer Institute Australia in 2003 as a Senior Research Officer.23 He was promoted to Project Leader in 2009 and became a Group Leader in 2011.23 Currently, he is an Associate Professor at the Lowy Cancer Research Centre, University of New South Wales.3
Research Focus
Dr. Liu's research primarily focuses on:
- Investigating the role of histones, transcriptional super-enhancers, and long noncoding RNAs in tumor formation.2
- Using genomics approaches to study critical genes and pathways driving neuroblastoma, particularly high-risk subtypes.2
- Developing novel targeted therapies for neuroblastoma, including inhibitors of long non-coding RNAs.24
Funding and Recognition
Dr. Liu has received funding from various organizations, including the National Institutes of Health USA, US Department of Defense, National Health & Medical Research Council, Cancer Council NSW, Tour de Cure, and Neuroblastoma Australia.5
It's important to note that while the query mentions a specific LinkedIn username (tao-liu-50826823), the provided search results do not contain information about this particular profile. Therefore, I cannot confirm if this username corresponds to the Dr. Tao Liu discussed above.


